Align Technology, Inc.

ALGN · NASDAQ · USD

Can Align return its North American retail channel to growth while international markets and DSOs carry volumes and margins keep expanding?

Last 4 earnings calls · through Q2 FY2026

Bull case

  • International and DSO growth

    The bull case is that growth now comes from international markets and dental service organizations, where Invisalign adoption is still early and rising.

  • Growing-patient product portfolio

    Invisalign First, the palatal expander and mandibular advancement let Align treat children earlier, widening the pool it can reach before braces do.

  • Margin from simplified products

    Simplified aligner configurations with fewer or no refinement aligners cost less to make, so a lower upfront price still improves gross margin and cash conversion.

  • Cost discipline and buybacks

    Restructuring savings, an outside operating review and a larger buyback are expected to lift operating margin further even on modest revenue growth.

Bear case

  • North American retail weakness

    The bear case is that the North American retail dentist channel stays weak, and marketing, financing and product changes have not fixed it.

  • Scanner revenue model change

    Shifting scanners toward leases, rentals and cheaper configurations lowers upfront revenue, and management has cut its scanner revenue outlook for the year.

  • Modest company revenue growth

    Company-wide revenue growth is guided well below the long-term plan, so margin improvement rests more on cost cuts than on a larger business.

  • China and U.K. pricing risk

    Chinese volume-based procurement and the U.K. VAT ruling could each pressure price or volume, and the China impact is not reflected in guidance.

Bull and bear points

Growth & Execution

In short: International markets and DSOs are growing fast, while the North American retail channel stays weak.

Bull · 3

  • International markets drove record Clear Aligner volumes

    EMEA, APAC and Latin America each grew double digits, so growth no longer depends on the soft North American retail channel.

    Q2 FY2026 call

  • DSOs, about a quarter of volumes, grow double digits

    Dental service organizations bring scale, standardized workflows and patient financing, and they grew double digits in every region last quarter.

    Q2 FY2026 call

  • Clear Aligner volume outlook raised

    At the start of the year the volume target was mid-single digits; management has since raised it to about 6%, citing financing, subscription products and DSO demand.

    Tone shiftQ4 FY2025 → Q2 FY2026
Bear · 3

  • North American retail channel has not recovered

    Management describes North America as stable rather than improving, says a stronger United States consumer is what the channel needs, and still calls the fix a top priority.

    Q2 FY2026 call

  • Scanner revenue guidance cut to a decline

    Systems and Services was previously expected to grow roughly with the company; it is now guided down 6% to 8% as cheaper configurations and leases take hold.

    Tone shiftQ4 FY2025 → Q2 FY2026

  • Revenue growth trails long-term plan

    Reported revenue grew 4.3% over the past year, well short of the annual growth rate the business delivered from 2020 through 2025.

    Q1 FY2026 call

Profitability & Financial Strength

In short: Gross margin is rising with product mix, while GAAP operating margin is reduced by restructuring charges.

Bull · 3

  • Product mix lifts gross margin

    Reported gross margin reached 71.7%, up 1.8 points, though management said a tariff refund also helped the quarter, so not all of it is run-rate.

    Filed financials

  • Margin target extended into 2027

    A year ago the commitment was at least 100 basis points of operating margin improvement for 2026; management now targets at least the same again in 2027.

    Tone shiftQ3 FY2025 → Q2 FY2026

  • Free cash flow and buybacks

    Free cash flow of $634 million over the last twelve months more than covers capital spending, and management raised its 2026 repurchase commitment.

    Filed financials
Bear · 3

  • GAAP operating margin declined

    Operating margin was 14.6%, down 1.5 points, as restructuring, accelerated depreciation and a U.K. VAT charge ran through the income statement.

    Filed financials

  • Direct printing margin dilution

    Management says printing aligners and attachments directly weighs on margins until it scales, so the cost benefit arrives years from now.

    Q2 FY2026 call

  • Margin gains need volume leverage

    Management says the margin improvement requires volume through the factories, which is harder to count on while revenue growth is guided below the long-term plan.

    Q4 FY2025 call

Market Position

In short: A large scanner base and growing-patient products widen reach, while China pricing and U.K. VAT are risks.

Bull · 2

  • Scanner installed base keeps expanding

    More than 125,000 active iTero scanners are in use, and each scan a doctor performs is a chance to start an Invisalign case in the same chair.

    Q1 FY2026 call

  • Growing-patient products widen the treatable market

    Invisalign First, the palatal expander and mandibular advancement let doctors treat younger children, competing with metal expanders and braces rather than only other clear aligners.

    Q1 FY2026 call
Bear · 2

  • China procurement could reset prices

    Volume-based procurement timing and scope remain unclear, and management says the 2026 guidance assumes no impact on either Chinese volume or price.

    Q4 FY2025 call

  • U.K. VAT adds liability

    The Upper Tribunal overturned the exemption, Align recorded about $37.5 million of tax and interest, and it must add VAT to invoices while holding list prices.

    Q2 FY2026 call